[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367210-105":59,"doc-detail-367210-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-role-of-molecular-biomarkers-in-the-diagnosis-prognosis-and-treatment-stratification-of-oral-squamous-cell-carcinoma-a-comprehensive-review","The role of molecular biomarkers in the diagnosis, prognosis, and treatment stratification of oral squamous cell carcinoma - A comprehensive review","","Oral squamous cell carcinoma (OSCC) is a highly prevalent head and neck cancer with substantial global health burden, worsened by frequent metastasis, recurrence, and treatment resistance. This comprehensive review explains how molecular biomarkers can enhance early diagnosis, improve prognostic forecasting, and guide treatment stratification. It covers genetic mutations, epigenetic alterations, dysregulated signaling, and specific biomarkers (e.g., Tp53, EGFR, CCND1, HPV), including non-invasive tests such as salivary proteins, ctDNA, and microRNAs. It also links prognostic markers to survival and immune checkpoint markers to immunotherapy response, and discusses predictive biomarkers for therapy selection. ",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-role-of-molecular-biomarkers-in-the-diagnosis-prognosis-and-treatment-stratification-of-oral-squamous-cell-carcinoma-a-comprehensive-review/367210/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-role-of-molecular-biomarkers-in-the-diagnosis-prognosis-and-treatment-stratification-of-oral-squamous-cell-carcinoma-a-comprehensive-review/367210.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are molecular biomarkers important for oral squamous cell carcinoma (OSCC)?","Question",{"text":112,"@type":113},"OSCC has high rates of metastasis and recurrence and a dismal outlook despite improved therapies. Molecular biomarkers can support earlier diagnosis, better prediction of patient outcomes, and more tailored therapeutic decisions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which molecular biomarker types are discussed for OSCC?",{"text":117,"@type":113},"The review highlights genetic mutations, epigenetic changes, dysregulated signaling pathways, and biomarker examples such as Tp53, EGFR-targeted biomarkers, CCND1, and HPV status.",{"name":119,"@type":110,"acceptedAnswer":120},"How do diagnostic biomarkers support non-invasive testing in OSCC?",{"text":121,"@type":113},"Non-invasive detection approaches are explored, including salivary proteins, circulating tumor DNA (ctDNA), and microRNAs, which may enable earlier intervention and improved outcomes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367210,1790482608,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","JLB 7 (2025) 100285  \nContents lists available at ScienceDirect  \nThe Journal of Liquid Biopsy  \njournal [homepage:](homepage: www.sciencedirect.com/journal/the-journal-of-liquid-biopsy)[ www.sciencedirect.com/journal/the-journal-of-liquid-biopsy](homepage: www.sciencedirect.com/journal/the-journal-of-liquid-biopsy)  \n| The role of molecular biomarkers in the diagnosis, prognosis, and treatment   stratification of oral squamous cell carcinoma: A comprehensive review\u003Cbr>Saravanan Ravindrana,* , Srinivasan Ranganathana, Karthikeyan Rb, Nandini Jc,\u003Cbr>Shanmugarathinam Ad, Senthil Kumar Kannane, Durga Prasad Kf, Jalaiah Marrig, Rajaganapathi Ka\u003Cbr>a Faculty of Pharmacy, Bharath Institute of Higher Education and Research, Chennai, 73, India b School of Pharmacy, Sri Balaji Vidyapeeth, SBV Campus, Pillayarkuppam, Puducherry, India\u003Cbr>c Saveetha college of pharmacy, Saveetha institute of medical and technical sciences, Chennai, 602105, India\u003Cbr>d Department of Pharmaceutical Technology, University College of Engineering, Bharathidasan Institute of Technology Campus, Anna University, Tiruchirappalli, 620024, India\u003Cbr>e Department of Pharmaceutics Karpagam college of pharmacy, Othakkalmandapam, Coimbatore, 32, India f K. V.S.R. Siddhartha College of Pharmaceutical Sciences, Vijayawada, Andhra Pradesh, 520008, India g QIS College of Pharmacy, Vengamukkapalem, Ongole, Andhra Pradesh, 523272, India |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords:\u003Cbr>Oral squamous cell carcinoma (OSCC) Molecular biomarkers\u003Cbr>Diagnosis\u003Cbr>Prognosis\u003Cbr>Treatment stratification |  | One of the most common cancers targeting the area of the head and neck is oral squamous cell carcinoma (OSCC), carrying a heavy global health cost. With a high incidence of metastasis and recurrence, the outlook for OSCC remains dismal despite advancements in treatment. This has sparked an investigation into molecular biomarkers, which have the potential to improve early diagnosis, forecast patient outcomes, and direct therapeutic approaches. An extensive summary of the function of molecular biomarkers in OSCC diagnosis, prognosis, and medical care stratification is given in this article. Complex genetic mutations, epigenetic changes, and dysregulated signalling pathways are all part of the aetiology of OSCC. Tumor protein p53 (Tp53), Epidermal growth factor receptor (EGFR-targeted), Cyclin D1 (CCND1), and Human papilloma virus (HPV) status are examples of molecular biomarkers that have demonstrated potential in recognising disease at an early stage and identifying malignant changes. The non-invasive detection capabilities of diagnostic biomarkers such as salivary proteins, circulating tumour DNA (ctDNA), and microRNAs are being explored more and more because they may provide early intervention and better patient outcomes. Prognostically, tumour aggressiveness, recurrence risk, and overall survival have all been linked to biomarkers such as matrix metalloproteinases (MMPs), E-cadherin, and different cytokines. Furthermore, immune checkpoints such as cytotoxic T-lymphocyte-associated protein 4 (CTLA- 4) and programmed death-ligand 1 (PD-L1) are becoming recognised as important markers of the tumour microenvironment’s function in the course of the disease and its reaction to immunotherapy. The significance of biomarkers in personalised medicine has been further highlighted by the recognition of subgroups with elevated risk that might gain benefit from more aggressive treatment options thanks to the genetic profiling of OSCC. Predictive biomarkers are essential for therapy classification because they allow therapeutic regimens to be tailored. For example, (Kirsten rat sarcoma viral oncogene homologous) KRAS mutations and EGFR expression influence the effectiveness of targeted therapies, and the existence of specific epigenetic markers influences choices about radiation or chemotherapy. It is expected that the incorporation of multi-omics techniq","cbCaiaDDBxfcLvws","https://ap.wps.com/l/cbCaiaDDBxfcLvws","pdf",784658,"English","# A R T I C L E I N F O\n## Keywords: Oral squamous cell carcinoma (OSCC), Molecular biomarkers, Diagnosis, Prognosis, Treatment stratification\n# Abstract\n## Molecular biomarkers in diagnosis, prognosis, and treatment stratification","[{\"question\":\"Why are molecular biomarkers important for oral squamous cell carcinoma (OSCC)?\",\"answer\":\"OSCC has high rates of metastasis and recurrence and a dismal outlook despite improved therapies. Molecular biomarkers can support earlier diagnosis, better prediction of patient outcomes, and more tailored therapeutic decisions.\"},{\"question\":\"Which molecular biomarker types are discussed for OSCC?\",\"answer\":\"The review highlights genetic mutations, epigenetic changes, dysregulated signaling pathways, and biomarker examples such as Tp53, EGFR-targeted biomarkers, CCND1, and HPV status.\"},{\"question\":\"How do diagnostic biomarkers support non-invasive testing in OSCC?\",\"answer\":\"Non-invasive detection approaches are explored, including salivary proteins, circulating tumor DNA (ctDNA), and microRNAs, which may enable earlier intervention and improved outcomes.\"}]","The role of molecular biomarkers in the diagnosis, prognosis, and treatment stratification of oral squamous cell carcinoma - A comprehensive review | PDF",1790169709,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1bc6427b6c77209d0f616361eb80916a.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6283ff05342381506aeeef65a7a01668.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fdf0732bc5f1bda7a80a0d20339f3115.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b456c55cd60b3b83ce1ead6387081a4.webp",980,1306]